Immunotherapy Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Immunotherapy Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Life Sciences
Medarex, Inc. describes research in life sciences
May 21st, 2008
A report, 'A high-throughput hybridoma selection method using fluorometric microvolume assay technology,' is newly published data in Journal of Biomolecular Screening. According to recent research from the United States, "Monoclonal antibodies (mAb) are not only useful reagents but also represent a promising type of therapeutics due to their high affinity and exquisite specificity for their antigens. A critical step in mAb generation is to identify antigen-specific antibodies." "Although enzyme-linked immunosorbent assay (ELISA) has been broadly applied for antibody selection against secreted antigens, an inherent disadvantage for ELISA is the difficulty in...
Source: Immunotherapy Weekly (2008-05-21)
|
